Showing results (321-330 of 403) with videos related to

Sort By:
Pageof 41
Vaccines|July 27, 2022
A Recombinant Chimeric Protein-Based Vaccine Containing T-Cell Epitopes from Amastigote Proteins and Combined with Distinct Adjuvants, Induces Immunogenicity and Protection against Leishmania infantum InfectionDaniela P Lage, Danniele L Vale, Flávia P Linhares, et al.
Pathogens (Basel, Switzerland)|December 31, 2025
Immunotherapeutics Combining a Recombinant Chimeric Protein, Monophosphoryl Lipid A, and Miltefosine Against Visceral LeishmaniasisMarcelo M Jesus, Daniela P Lage, Breno L Pimenta, et al.
Plants (Basel, Switzerland)|February 6, 2021
Effect of Rice Grain (Oryza sativa L.) Enrichment with Selenium on Foliar Leaf Gas Exchanges and Accumulation of NutrientsAna Coelho Marques, Fernando C Lidon, Ana Rita F Coelho, et al.
Clinical Oral Investigations|November 23, 2020
Moderate and severe periodontitis are positively associated with metabolic syndromeIsaac Suzart Gomes-Filho, Izadora da S C E Balinha, Simone S da Cruz, et al.
Molecular Immunology|February 2, 2023
Recombinant endonuclease III protein from Leishmania infantum associated with Th1-type adjuvants is immunogenic and induces protection against visceral leishmaniasisDaniela P Lage, Amanda S Machado, Camila S Freitas, et al.
Research in Veterinary Science|August 16, 2019
Diagnostic markers selected by immunoproteomics and phage display applied for the serodiagnosis of canine leishmaniosisJuliana M Machado, Lourena E Costa, Daniel S Dias, et al.
Experimental Parasitology|March 21, 2024
Treatment using vanillin-derived synthetic molecules incorporated into polymeric micelles is effective against infection caused by Leishmania amazonensis speciesIsabela A G Pereira, Camila S Freitas, Raquel S B Câmara, et al.
Cytokine|February 19, 2024
New synthetic molecules incorporated into polymeric micelles used for treatment against visceral leishmaniasisCamila S Freitas, Isabela A G Pereira, Daniela P Lage, et al.
Microbial Pathogenesis|June 3, 2020
Biotechnological applications from a Leishmania amastigote-specific hypothetical protein in the canine and human visceral leishmaniasisJoão A Oliveira-da-Silva, Amanda S Machado, Grasiele S V Tavares, et al.
Parasitology Research|October 19, 2021
ChimLeish, a new recombinant chimeric protein evaluated as a diagnostic and prognostic marker for visceral leishmaniasis and human immunodeficiency virus coinfectionNathalia C Galvani, Amanda S Machado, Daniela P Lage, et al.
Pageof 41